Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland
INSPIRE Asthma Patient Survey to Clarify the Use of Asthma Medication and Effects of Asthma in Everyday Life in Finland
1 other identifier
observational
142
0 countries
N/A
Brief Summary
This study was aimed at clarifying how the asthma medication is used in practice and how asthma affects everyday life. Total of 106 GPs were asked to recruit patients using inhaled steroid as maintenance treatment for asthma to take part in a telephone survey. Altogether 142 patients were interviewed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2006
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 19, 2008
CompletedFirst Posted
Study publicly available on registry
May 21, 2008
CompletedJanuary 24, 2011
January 1, 2011
6 months
May 19, 2008
January 21, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients perceptions about treatment of asthma, asthma medication and what are the most common triggers that cause exacerbations.
Single occasion
Secondary Outcomes (2)
How patients react to the first signs of worsening of asthma i.e. how they use asthma medication during stable phase and asthma exacerbation
Single occasion
How asthma affects everyday life
Single occasion
Study Arms (1)
1
Asthma patients using inhaled steroids as maintenance treatment
Eligibility Criteria
Primary care clinic
You may qualify if:
- Diagnosed persistent asthma
- regular use of inhaled steroids and concomitant medication
You may not qualify if:
- never been diagnosed COPD
- seasonal asthma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Airi Puhakka
AstraZeneca Finland
- PRINCIPAL INVESTIGATOR
Jouni Hedman
South Karelia Central Hospital, Finland
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 19, 2008
First Posted
May 21, 2008
Study Start
October 1, 2006
Primary Completion
April 1, 2007
Study Completion
April 1, 2007
Last Updated
January 24, 2011
Record last verified: 2011-01